《異動》鴻騰精密(06088.HK)午後升幅擴至逾26%創七年半高 不足兩周累升近1.2倍
鴻騰精密(06088.HK)今早(15日)低開1.8%後轉勢急升,午後升幅進一步擴大,曾升約28%,高見5.74元創2018年1月以來約七年半高,最新報5.65元,升26.12%,成交3.71億股,涉資19.25億元。
以8月4日收市價2.57元計,不足兩周累升近1.2倍。
鴻騰精密日前公布6月底止六個月中期業績,錄得純利3,151萬美元,倒退3.1%。招銀國際研究報告則指出,即使公司基於關稅及宏觀不確定性,下調智能手機、消費者互聯及系統產品指引,但基於雲與人工智能伺服器產品及AirPod生產提速,對公司「3+3戰略」在明年及2027年表現持正面觀點,予評級「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.